I don't think there is any doubt that something quite amiss is behind remdesivir's quick sailing thru the FDA procedure, the complete lack of positive test results, the safety issues, and the missing data common in all other testing of drugs attempting to kill a virus.

IMO it screams some sort of massive payoff down the line somewhere, but that is simply my gut feeling.

On the other hand, Brilacidin data comes in as clean as a whistle with IPIX having NO INPUT WHATSOEVER with the test results, they all being obtained from a government RBL. There should be absolutely no discussion as to hanky panky with the Brilacidin test data and the absolute requirement for an immediate human trial.

I am really looking forward to next week as I do believe it could be the introduction of Brilacidin and its oh-so-many benefits and solid safety profile to the world, not just to medicine but the actual entire world.

To have the creator of the drug as a scientific advisor and to have him so highly acclaimed already in the world of medicine is another tremendous shot in the arm for IPIX. All systems go, gentlemen, start your engines.